Cargando…
Alloreactive CD154-expressing T-cell subsets with differential sensitivity to the immunosuppressant, belatacept: potential targets of novel belatacept-based regimens
Belatacept blocks CD28-mediated T-cell costimulation and prevents renal transplant rejection. Understanding T-cell subset sensitivity to belatacept may identify cellular markers for immunosuppression failure to better guide treatment selection. Here, we evaluate the belatacept sensitivity of allo-an...
Autores principales: | Ashokkumar, Chethan, Ganguly, Bishu, Townsend, Robert, White, Jaimie, Levy, Samantha, Moritz, Michael, Mazariegos, George, Sun, Qing, Sindhi, Rakesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607954/ https://www.ncbi.nlm.nih.gov/pubmed/26472085 http://dx.doi.org/10.1038/srep15218 |
Ejemplares similares
-
Belatacept for Maintenance Immunosuppression in Lung Transplantation
por: Hui, Christine, et al.
Publicado: (2014) -
Belatacept-based immunosuppressive regimen in HIV-positive kidney transplant recipients
por: El Sakhawi, Karim, et al.
Publicado: (2020) -
Conversion From Belatacept to Another Immunosuppressive Regimen in Maintenance Kidney-Transplantation Patients
por: Gouin, Anna, et al.
Publicado: (2020) -
Belatacept: Good, but not good enough?
por: Parameswaran, Sreejith, et al.
Publicado: (2012) -
Belatacept: the challenges with transformational drugs
por: Vincenti, Flavio
Publicado: (2017)